NOCIL Limited

NSE:NOCIL.NS

179.9 (INR) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12013 Q42013 Q32012 Q42012 Q32012 Q22012 Q1
Revenue 3,181.33,6273,721.73,5653,406.23,508.83,966.73,927.23,257.23,892.35,0894,526.83,889.13,751.63,4453,103.92,745.72,215.91,065.12,041.21,943.12,097.32,295.92,290.42,612.42,719.92,680.91,743.1391,456.31,176.5861,1351,265.71,276.9
Cost of Revenue 1,7652,424.32,5682,396.81,829.91,981.62,6482,335.31,759.22,056.72,725.62,310.82,309.72,230.61,7421,797.71,552.41,150.6545.61,062.8927.2886.71,001.71,109.41,174.71,1941,190.11,022.215758-80.447985.91,132.81,121.9
Gross Profit 1,416.31,202.71,153.71,168.21,576.31,527.21,318.71,591.91,4981,835.62,363.42,2161,579.41,5211,7031,306.21,193.31,065.3519.5978.41,015.91,210.61,294.21,1811,437.71,525.91,490.8720.924698.31,257.033149.1132.9155
Gross Profit Ratio 0.4450.3320.310.3280.4630.4350.3320.4050.460.4720.4640.490.4060.4050.4940.4210.4350.4810.4880.4790.5230.5770.5640.5160.550.5610.5560.4140.481.0680.1310.1050.121
Reseach & Development Expenses 00071.900061.300055.700055.200051.800046.5000000000
General & Administrative Expenses 000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000
SG&A 0958.2874.9855.1849835.3893.2208.9908.41,003.11,097.11,000.5877.8823.2751.7727.3182.3182164.7222.6193.6190.5202263.7159.8168.8187.8000000
Other Expenses 1,311.7093.4242.958.346.346.428.222.18.61,474.3-22.84.913.711.1-129.916.910.2107.4-56.213.920.725.9-72.121.228.126.6643.18524.71,409.35283.953.727.8
Operating Expenses 1,311.7958.2874.9855.11,222.71,205893.21,232.11,263.91,355.11,474.31,248.71,180.11,1251,074.2864.5906.7839.9531.2706.6732.7806.2808.1604.2767787748.5643.18524.71,409.35283.953.727.8
Operating Income 104.6244.5278.8313.1411.9368.5425.5373.8256.2489.1899.6951.2399.3396628.8441.7286.6225.4-11.7271.8283.2404.4486.1576.8670.7738.9742.3140.188129.5-152.31965.279.2127.2
Operating Income Ratio 0.0330.0670.0750.0880.1210.1050.1070.0950.0790.1260.1770.210.1030.1060.1830.1420.1040.102-0.0110.1330.1460.1930.2120.2520.2570.2720.2770.080.089-0.1290.0570.0630.1
Total Other Income Expenses Net 86.378.888.8242.953.3-3.246.111.5-3.15.27.7-7.92.111.88.82.314.57.6104.927.110.717.422.7-22.620.526.823.93.6750336.095-8.6-5.7-2.8
Income Before Tax 190.9323.3367.6556406.9365.3471.6385.3253.1485.7896.8959.4401.4407.8637.6444301.123393.2298.9293.9421.8508.8554.2691.2765.7766.2143.863129.5183.77656.673.5124.4
Income Before Tax Ratio 0.060.0890.0990.1560.1190.1040.1190.0980.0780.1250.1760.2120.1030.1090.1850.1430.110.1050.0880.1460.1510.2010.2220.2420.2650.2820.2860.0830.0890.1560.050.0580.097
Income Tax Expense 61.9-9897140.6106.993.7128.6102.166.9128.4232270.2103.5107.9163.570.77864.8-26.380.284-127.5180192.3242.5237.2257.140.72346.8-39.1682.51637.5
Net Income 129421.3270.6415.5300271.6343283.2186.2357.3664.8689.2297.9299.9474.1373.3223.1168.2119.5218.7209.9549.3328.8361.9448.7528.5509.1103.1482.7222.94454.157.586.9
Net Income Ratio 0.0410.1160.0730.1170.0880.0770.0860.0720.0570.0920.1310.1520.0770.080.1380.120.0810.0760.1120.1070.1080.2620.1430.1580.1720.1940.190.0590.0570.1890.0480.0450.068
EPS 0.772.531.622.491.81.632.061.71.122.143.994.141.791.82.852.241.341.020.721.331.273.321.992.192.713.23.080.630.511.350.340.360.54
EPS Diluted 0.762.521.622.481.791.632.051.71.112.133.984.141.781.792.842.241.331.020.721.331.273.321.982.192.73.183.060.630.511.350.340.360.54
EBITDA 331.1462.1482.575693.3546.8499.2604.7526.7397.9628.61,036.51,126.3512.4516.5745.3546.8394.4326.9187.2397.2379.7505.4591.7622.8751.5826.1826.4221.098217.8240.83482.997.2145
EBITDA Ratio 0.1040.1270.130.1940.1610.1420.1520.1340.1220.1610.2040.2490.1320.1380.2160.1760.1440.1480.1760.1950.1950.2410.2580.2720.2880.3040.3080.1270.150.2050.0730.0770.114